Inflammatory bowel disease and guillain barre syndrome in FCHO1 deficiency

dc.authorid0000-0002-4551-5433
dc.authorid0000-0002-9710-8653
dc.contributor.authorAydemir, Sezin
dc.contributor.authorİşlek, Ali
dc.contributor.authorNepesov, Serdar
dc.contributor.authorYaman, Yöntem
dc.contributor.authorBaysoy, Gökhan
dc.contributor.authorBeşer, Ömer Faruk
dc.contributor.authorÇullu Çokuğraş, Fügen
dc.contributor.authorBarış, Safa
dc.contributor.authorKarakoç Aydıner, Elif
dc.contributor.authorÇokuğraş, Haluk
dc.contributor.authorHubrack, Satanay Z.
dc.contributor.authorKendir Demirkol, Yasemin
dc.contributor.authorLo, Bernice
dc.contributor.authorKıykım, Ayça
dc.contributor.authorÖzen, Ahmet
dc.date.accessioned2021-10-14T09:48:48Z
dc.date.available2021-10-14T09:48:48Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.description.abstractTo the Editor: FCH And Mu Domain Containing Endocytic Adaptor 1 (FCHO1) gene encodes a protein that plays a critical role in clathrin-mediated endocytosis, a biological process that maintains cellular functions in signaling, nutrient- and growth factor- uptake, and diferentiation [1–3]. Recently, biallelic mutations in FCHO1 were linked to a combined immunodefciency that is characterized by recurrent infections caused by bacteria, viruses, mycobacteria, fungi, T cell lymphopenia, and hypogammaglobulinemia [4, 5].
dc.description.sponsorshipSidra Precision Medicine Programen_US
dc.identifier.citationAydemir, S., İşlek, A., Nepesov, S., Yaman, Y., Baysoy, G., Beşer, Ö. F. ... Özen, A. (2021). Inflammatory bowel disease and guillain barre syndrome in FCHO1 deficiency. Journal of Clinical Immunology, 41(6), 1406-1410. https://dx.doi.org/10.1007/s10875-021-01042-2
dc.identifier.doi10.1007/s10875-021-01042-2
dc.identifier.endpage1410
dc.identifier.issn0271-9142
dc.identifier.issn1573-2592
dc.identifier.issue6
dc.identifier.scopusqualityQ1
dc.identifier.startpage1406
dc.identifier.urihttps://dx.doi.org/10.1007/s10875-021-01042-2
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8450
dc.identifier.volume41
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofJournal of Clinical Immunologyen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectFCHO1 Deficiency
dc.subjectGuillain Barre Syndrome
dc.subjectBowel Disease
dc.titleInflammatory bowel disease and guillain barre syndrome in FCHO1 deficiency
dc.typeEditorial

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Nepesov-Serdar-2021.pdf
Boyut:
1.12 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: